Literature DB >> 18835861

Early onset of hypokalaemic periodic paralysis caused by a novel mutation of the CACNA1S gene.

S Chabrier1, N Monnier, J Lunardi.   

Abstract

We report a precocious and atypical form of hypokalaemic periodic paralysis, with clinical manifestations at birth and first episodes of paralysis occurring as early as 1 year of age, although onset of this disease usually occurs between 5-35 years. Extensive molecular analysis showed that the disease was caused by a novel de novo p.Arg897Ser mutation in the CACNA1S gene. The mutation mapped to a new region of the protein, the S4 voltage sensing segment of domain III, at odds with previously reported mutations that exclusively affected domains II and IV.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18835861     DOI: 10.1136/jmg.2008.059766

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  9 in total

1.  A novel mutation in CACNA1S gene associated with hypokalemic periodic paralysis which has a gender difference in the penetrance.

Authors:  Fei-Feng Li; Qian-Qian Li; Zhen-Xuan Tan; Si-Yao Zhang; Ji Liu; Er-ying Zhao; Gui-Chun Yu; Jin Zhou; Li-Ming Zhang; Shu-Lin Liu
Journal:  J Mol Neurosci       Date:  2011-08-16       Impact factor: 3.444

Review 2.  Muscle channelopathies: does the predicted channel gating pore offer new treatment insights for hypokalaemic periodic paralysis?

Authors:  E Matthews; M G Hanna
Journal:  J Physiol       Date:  2010-02-01       Impact factor: 5.182

3.  Exploring the utility of whole-exome sequencing as a diagnostic tool in a child with atypical episodic muscle weakness.

Authors:  Neil A Hanchard; David R Murdock; Pilar L Magoulas; Matthew Bainbridge; Donna Muzny; YuanQing Wu; Min Wang; James R Lupski; Richard A Gibbs; Chester W Brown
Journal:  Clin Genet       Date:  2012-09-11       Impact factor: 4.438

Review 4.  Skeletal muscle channelopathies: new insights into the periodic paralyses and nondystrophic myotonias.

Authors:  Daniel Platt; Robert Griggs
Journal:  Curr Opin Neurol       Date:  2009-10       Impact factor: 5.710

5.  Mutations associated with hypokalemic periodic paralysis: from hotspot regions to complete analysis of CACNA1S and SCN4A genes.

Authors:  Raffaella Brugnoni; Eleonora Canioni; Massimiliano Filosto; Antonella Pini; Paola Tonin; Tommaso Rossi; Carlotta Canavese; Marica Eoli; Gabriele Siciliano; Giuseppe Lauria; Renato Mantegazza; Lorenzo Maggi
Journal:  Neurogenetics       Date:  2021-10-05       Impact factor: 2.660

6.  Pathophysiological role of omega pore current in channelopathies.

Authors:  Karin Jurkat-Rott; James Groome; Frank Lehmann-Horn
Journal:  Front Pharmacol       Date:  2012-06-11       Impact factor: 5.810

7.  PharmGKB summary: very important pharmacogene information for CACNA1S.

Authors:  Katrin Sangkuhl; Robert T Dirksen; Maria L Alvarellos; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2020-02       Impact factor: 2.000

8.  Gating pore currents occur in CaV1.1 domain III mutants associated with HypoPP.

Authors:  Fenfen Wu; Marbella Quinonez; Stephen C Cannon
Journal:  J Gen Physiol       Date:  2021-08-31       Impact factor: 4.086

9.  The role of CACNA1S in predisposition to malignant hyperthermia.

Authors:  Danielle Carpenter; Christopher Ringrose; Vincenzo Leo; Andrew Morris; Rachel L Robinson; P Jane Halsall; Philip M Hopkins; Marie-Anne Shaw
Journal:  BMC Med Genet       Date:  2009-10-13       Impact factor: 2.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.